ArticleLeukemia2025

Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.

Qiangqiang Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.